QT interval shortening in spontaneous reports submitted to the FDA: the need for consensus

Eitemau Tebyg

• Assessing liver injury associated with antimycotics: Concise literature review and clues from data mining of the FAERS database
  gan: Raschi, Emanuel, et al.
  Cyhoeddwyd: (2014)
• Antipsychotics and Torsadogenic Risk: Signals Emerging from the US FDA Adverse Event Reporting System Database
  gan: Poluzzi, Elisabetta, et al.
  Cyhoeddwyd: (2013)
• Thromboembolic Events with Cyclin-Dependent Kinase 4/6 Inhibitors in the FDA Adverse Event Reporting System
  gan: Raschi, Emanuel, et al.
  Cyhoeddwyd: (2021)
• Cyclin-dependent kinase 4/6 inhibitors and interstitial lung disease in the FDA adverse event reporting system: a pharmacovigilance assessment
  gan: Raschi, Emanuel, et al.
  Cyhoeddwyd: (2020)
• Use of phytoestrogens and effects perceived by postmenopausal women: result of a questionnaire-based survey
  gan: Girardi, Anna, et al.
  Cyhoeddwyd: (2014)